Research Notes

BPC-157

The repair signal.

  • Lyophilised powder
    Format
  • 20–60 days
    Vial coverage
  • 2 mL BAC water
    Reconstitution
Continue reading
Overview

What it is, in plain language

BPC-157 is a 15-amino-acid pentadecapeptide derived from a protective sequence in human gastric juice. In the research literature it is among the most-studied regenerative peptides — investigated for its ability to support tissue repair, gut-lining recovery, and vascular regrowth at sites of injury.

It sits at the foundation of the AEON regenerative line because the mechanism is broad: BPC-157 acts as a signal, not a substrate. Almost every other compound in the recovery stack works downstream of, or alongside, the pathways BPC-157 activates.

BPC-157 acts as a signal, not a substrate — almost every other compound in the recovery stack works downstream of the pathways it activates.
Mechanism

How it works

Research suggests BPC-157 drives angiogenesis (the formation of new blood vessels), modulates nitric-oxide signalling, and upregulates growth-factor expression at injury sites. Its protective effects on the GI tract are believed to relate to mucosal-barrier restoration and prostaglandin pathway interaction.

Research findings

What the literature shows

Animal studies report accelerated healing of tendons, ligaments, muscle, and gastric tissue, with notable effects on wound closure and granulation.

Anti-inflammatory and neuroprotective effects have been observed across multiple preclinical models. Human clinical data remains limited and primarily preliminary.

Cycle & Handling

Protocol reference

Common research-grade reference figures. Not medical advice — every protocol must be reviewed against the latest published literature and your study design.

Cycle guidance

Standard 4–6 weeks on, 2–4 weeks off. Extended option 8–12 weeks for chronic tendon or GI work, followed by a 4-week washout. Annual ceiling commonly observed: 2–3 full cycles. Stacks naturally with TB-500 and GHK-Cu within the same cycle window; MOTS-c runs in parallel without overlap.

Reconstitution

2 mL bacteriostatic water → 5 mg/mL. Draw 0.05 mL = 0.25 mg; 0.10 mL = 0.5 mg.

Storage

Lyophilised vial: room temperature short-term, refrigerator long-term. Reconstituted: refrigerate; use within 28 days when reconstituted with bacteriostatic water.

FAQ

Common questions

Why is BPC-157 considered foundational?

Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.

Subcutaneous vs oral — what does the research show?

Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.

Can BPC-157 be stacked with TB-500?

Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.

How long does a reconstituted vial last?

Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.

When should I use standalone BPC-157 vs the BPC+TB blend or GLOW?

Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.

Ready to source

BPC-157 — research-grade, third-party HPLC tested

Body Protection Compound 157 · 99% HPLC purity

Shop BPC-157
Often paired with
Products supplied by AEON are intended for in-vitro research and laboratory use only. They are not approved by the TGA or any other regulatory body for human consumption, therapeutic use, or any clinical application. Information presented here references published research and is provided for educational purposes. Nothing on this site constitutes medical advice. Customers are responsible for compliance with all local laws.